“I think he has indicated on many occasions that
Post# of 148181
He has mentioned a 3 figure SP multiple times. And if I remember correctly, he even mentioned a 4 figure SP at one point give them the multiple immunologic conditions that leronlimab could treat.
I’d like to believe that his $100 SP prediction isn’t preventing him from considering a buyout now or in the future that’s less then $100, especially if that offer includes stock from the company making the BO. I’ll take a BO now if it includes cash and stock.